These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33336782)

  • 1. CD147 as an alternative binding site for the spike protein on the surface of SARS-CoV-2.
    Faghihi H
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):11992-11994. PubMed ID: 33336782
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor markers as an entry for SARS-CoV-2 infection?
    Xia P; Dubrovska A
    FEBS J; 2020 Sep; 287(17):3677-3680. PubMed ID: 32738184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta, alpha, beta, and gamma.
    Geng J; Chen L; Yuan Y; Wang K; Wang Y; Qin C; Wu G; Chen R; Zhang Z; Wei D; Du P; Zhang J; Lin P; Zhang K; Deng Y; Xu K; Liu J; Sun X; Guo T; Yang X; Wu J; Jiang J; Li L; Zhang K; Wang Z; Zhang J; Yan Q; Zhu H; Zheng Z; Miao J; Fu X; Yang F; Chen X; Tang H; Zhang Y; Shi Y; Zhu Y; Pei Z; Huo F; Liang X; Wang Y; Wang Q; Xie W; Li Y; Shi M; Bian H; Zhu P; Chen ZN
    Signal Transduct Target Ther; 2021 Sep; 6(1):347. PubMed ID: 34564690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein.
    Ragotte RJ; Pulido D; Donnellan FR; Hill ML; Gorini G; Davies H; Brun J; McHugh K; King LDW; Skinner K; Miura K; Long CA; Zitzmann N; Draper SJ
    mSphere; 2021 Aug; 6(4):e0064721. PubMed ID: 34378982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of the potential interaction of SARS-CoV-2 spike protein to CD147 in COVID-19 associated-lymphopenia.
    Helal MA; Shouman S; Abdelwaly A; Elmehrath AO; Essawy M; Sayed SM; Saleh AH; El-Badri N
    J Biomol Struct Dyn; 2022 Feb; 40(3):1109-1119. PubMed ID: 32936048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2-associated lymphopenia: possible mechanisms and the role of CD147.
    Shouman S; El-Kholy N; Hussien AE; El-Derby AM; Magdy S; Abou-Shanab AM; Elmehrath AO; Abdelwaly A; Helal M; El-Badri N
    Cell Commun Signal; 2024 Jul; 22(1):349. PubMed ID: 38965547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of SARS-CoV-2 receptor ACE2 and CD147, and protease TMPRSS2 in human and mouse brain cells and mouse brain tissues.
    Qiao J; Li W; Bao J; Peng Q; Wen D; Wang J; Sun B
    Biochem Biophys Res Commun; 2020 Dec; 533(4):867-871. PubMed ID: 33008593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of SARS-CoV-2 entry in gingival epithelial cells expressing CD147.
    Bontempo A; Chirino A; Heidari A; Boparai S; Arora S; Ruiz S; Antonson SA; Kawai T; Cayabyab MJ
    Eur J Oral Sci; 2023 Feb; 131(1):e12906. PubMed ID: 36412995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease.
    Avolio E; Carrabba M; Milligan R; Kavanagh Williamson M; Beltrami AP; Gupta K; Elvers KT; Gamez M; Foster RR; Gillespie K; Hamilton F; Arnold D; Berger I; Davidson AD; Hill D; Caputo M; Madeddu P
    Clin Sci (Lond); 2021 Dec; 135(24):2667-2689. PubMed ID: 34807265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emerging plasticity of SARS-CoV-2.
    McCormick KD; Jacobs JL; Mellors JW
    Science; 2021 Mar; 371(6536):1306-1308. PubMed ID: 33766871
    [No Abstract]   [Full Text] [Related]  

  • 11. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells.
    Wang K; Chen W; Zhang Z; Deng Y; Lian JQ; Du P; Wei D; Zhang Y; Sun XX; Gong L; Yang X; He L; Zhang L; Yang Z; Geng JJ; Chen R; Zhang H; Wang B; Zhu YM; Nan G; Jiang JL; Li L; Wu J; Lin P; Huang W; Xie L; Zheng ZH; Zhang K; Miao JL; Cui HY; Huang M; Zhang J; Fu L; Yang XM; Zhao Z; Sun S; Gu H; Wang Z; Wang CF; Lu Y; Liu YY; Wang QY; Bian H; Zhu P; Chen ZN
    Signal Transduct Target Ther; 2020 Dec; 5(1):283. PubMed ID: 33277466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2.
    Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
    Cells; 2021 Jun; 10(6):. PubMed ID: 34201214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor.
    Shilts J; Crozier TWM; Greenwood EJD; Lehner PJ; Wright GJ
    Sci Rep; 2021 Jan; 11(1):413. PubMed ID: 33432067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How kids' immune systems can evade COVID.
    Nogrady B
    Nature; 2020 Dec; 588(7838):382. PubMed ID: 33303982
    [No Abstract]   [Full Text] [Related]  

  • 15. Relevance of VEGF and CD147 in different SARS-CoV-2 positive digestive tracts characterized by thrombotic damage.
    Bortolotti D; Simioni C; Neri LM; Rizzo R; Semprini CM; Occhionorelli S; Laface I; Sanz JM; Schiuma G; Rizzo S; Varano G; Beltrami S; Gentili V; Gafà R; Passaro A
    FASEB J; 2021 Dec; 35(12):e21969. PubMed ID: 34822202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy and coronavirus infection - a Trojan horse or Achilles heel?
    Seiler K; Tschan MPP
    Swiss Med Wkly; 2021 Jan; 151():w20468. PubMed ID: 33516163
    [No Abstract]   [Full Text] [Related]  

  • 17. Peptide Platform as a Powerful Tool in the Fight against COVID-19.
    Murdocca M; Citro G; Romeo I; Lupia A; Miersch S; Amadio B; Bonomo A; Rossi A; Sidhu SS; Pandolfi PP; Alcaro S; Sangiuolo FC; Novelli G
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of livestock and companion animals to COVID-19.
    Sreenivasan CC; Thomas M; Wang D; Li F
    J Med Virol; 2021 Mar; 93(3):1351-1360. PubMed ID: 33090532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein-ACE2 interaction.
    Lin C; Li Y; Zhang Y; Liu Z; Mu X; Gu C; Liu J; Li Y; Li G; Chen J
    Signal Transduct Target Ther; 2021 May; 6(1):198. PubMed ID: 34006835
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.